2.74
Precedente Chiudi:
$3.02
Aprire:
$2.91
Volume 24 ore:
775.60K
Relative Volume:
1.41
Capitalizzazione di mercato:
$165.87M
Reddito:
-
Utile/perdita netta:
$-69.31M
Rapporto P/E:
-2.1575
EPS:
-1.27
Flusso di cassa netto:
$-62.80M
1 W Prestazione:
-6.16%
1M Prestazione:
-33.82%
6M Prestazione:
-44.08%
1 anno Prestazione:
+15.13%
Rezolute Inc Stock (RZLT) Company Profile
Nome
Rezolute Inc
Settore
Industria
Telefono
650-206-4507
Indirizzo
275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY
Confronta RZLT con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
RZLT
Rezolute Inc
|
2.74 | 165.87M | 0 | -69.31M | -62.80M | -1.27 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
484.01 | 124.29B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
610.64 | 68.39B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
590.06 | 35.99B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
262.16 | 33.93B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
264.32 | 28.47B | 3.81B | -644.79M | -669.77M | -6.24 |
Rezolute Inc Stock (RZLT) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-11-05 | Iniziato | Wedbush | Outperform |
2024-08-27 | Iniziato | Guggenheim | Buy |
2024-07-17 | Iniziato | BTIG Research | Buy |
2024-06-04 | Iniziato | Craig Hallum | Buy |
2024-04-09 | Iniziato | Maxim Group | Buy |
2022-08-02 | Ripresa | Canaccord Genuity | Buy |
2022-06-15 | Iniziato | Cantor Fitzgerald | Overweight |
2021-09-08 | Iniziato | ROTH Capital | Buy |
2021-05-27 | Iniziato | Oppenheimer | Outperform |
2021-05-25 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Rezolute Inc Borsa (RZLT) Ultime notizie
Despite Recent Gains, Rezolute Insiders Are Still Down US$77k - simplywall.st
Brokerages Set Rezolute, Inc. (NASDAQ:RZLT) PT at $24.38 - Defense World
Charles Schwab Investment Management Inc. Purchases 9,000 Shares of Rezolute, Inc. (NASDAQ:RZLT) - Defense World
Rezolute Director Makes Bold Stock Purchase - TipRanks
Rezolute director Hogenhuis purchases $19,733 in common shares - Investing.com
rezolute CEO Elam Nevan buys $34,999 in common shares By Investing.com - Investing.com Australia
rezolute CEO Elam Nevan buys $34,999 in common shares - Investing.com
Rezolute’s CFO Makes Bold Move with Major Stock Purchase! - TipRanks
Rezolute Appoints Erik Harris to Board of Directors - TipRanks
Rezolute CFO Daron Evans acquires $57,700 in common shares - Investing.com India
Rezolute Inc (NASDAQ: RZLT): Getting A Free Pass? - Stocks Register
Rezolute expands board with biopharma veteran Erik Harris By Investing.com - Investing.com South Africa
Rezolute expands board with biopharma veteran Erik Harris - Investing.com
Rezolute Announces Appointment of Rare Disease Commercial Leader Erik Harris to its Board of Directors - The Manila Times
Strategic Move: Ultragenyx CCO Erik Harris to Drive Rezolute's Rare Disease Commercialization - Stock Titan
Comparing Rezolute (NASDAQ:RZLT) & Akero Therapeutics (NASDAQ:AKRO) - Defense World
Here's Why Rezolute (RZLT) Looks Ripe for Bottom Fishing - Nasdaq
Analysts Set Rezolute, Inc. (NASDAQ:RZLT) Price Target at $24.38 - Defense World
JMP Securities lifts Rezolute stock target to $9, maintains rating - MSN
Rezolute, Inc. (NASDAQ:RZLT) Receives Average Rating of "Buy" from Analysts - MarketBeat
A Guide To The Risks Of Investing In Rezolute Inc (RZLT) - Knox Daily
Insider Buying: Wladimir Hogenhuis Acquires Additional Shares of Rezolute Inc (RZLT) - GuruFocus.com
Rezolute director Wladimir Hogenhuis purchases $47,000 in common shares By Investing.com - Investing.com Nigeria
Rezolute director Wladimir Hogenhuis purchases $47,000 in common shares - Investing.com India
Hedge Fund and Insider Trading News: Scott Bessent, Warren Buffett, Stanley Druckenmiller, Tybourne Capital Management, Millennium Management, Rezolute Inc (RZLT), Rambus Inc (RMBS), and More - Insider Monkey
Insider Trading Highlights: Wednesday's Key Moves in US Stocks - Investing.com
Short Interest in Rezolute, Inc. (NASDAQ:RZLT) Rises By 17.4% - MarketBeat
Rezolute director Kim Young-Jin buys $5 million in shares By Investing.com - Investing.com Australia
Rezolute director Kim Young-Jin buys $5 million in shares - Investing.com
Rezolute's SWOT analysis: biotech stock advances on ersodetug trials - MSN
Rezolute (NASDAQ:RZLT) Receives "Buy" Rating from HC Wainwright - MarketBeat
JMP Securities Issues Positive Forecast for Rezolute (NASDAQ:RZLT) Stock Price - MarketBeat
Rezolute: Late-Stage Study Targeting Hyperinsulinism (NASDAQ:RZLT) - Seeking Alpha
Rezolute’s SWOT analysis: biotech stock advances on ersodetug trials By Investing.com - Investing.com Nigeria
What is Wedbush’s Estimate for Rezolute FY2029 Earnings? - Defense World
What is Wedbush's Estimate for Rezolute FY2029 Earnings? - MarketBeat
What is HC Wainwright’s Estimate for Rezolute Q1 Earnings? - Defense World
Rezolute (NASDAQ:RZLT) Releases Quarterly Earnings Results, Beats Estimates By $0.11 EPS - MarketBeat
Rezolute’s Strategic Advances in Rare Disease Therapies - MSN
Guggenheim Reiterates Buy Rating for Rezolute (NASDAQ:RZLT) - MarketBeat
JMP Securities lifts Rezolute stock target to $9, maintains rating By Investing.com - Investing.com Australia
Rezolute Inc Azioni (RZLT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):